TIDMABDX

RNS Number : 3299W

Abingdon Health PLC

21 December 2021

21 December 2021

Abingdon Health plc

("Abingdon" or "the Company")

Director/PDMR Dealings

York, U.K. 21 December 2021: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, confirms the participation of certain Directors in the Second Placing, pursuant to the Fundraising announced on 1 December 2021.

Director Participation in the Placing

 
 Participating      Number of         Number of           Number of       Percentage 
  Director           Existing    Placing Shares            Ordinary      of Enlarged 
                     Ordinary        subscribed         Shares held    Share Capital 
                       Shares        for in the           following     on Admission 
                                        Placing    Second Admission 
 Dr Christopher 
  Hand             11,228,868           999,599          12,228,467            10.0% 
                  -----------  ----------------  ------------------  --------------- 
 Chris Yates        6,513,844         1,000,000           7,513,844             6.2% 
                  -----------  ----------------  ------------------  --------------- 
 

Concert Party Interests

Following completion of the Fundraising, the interests of the Concert Party have reduced to 35.8 per cent. of the Company's total voting rights.

Capitalised terms used in this announcement shall have the same meanings as defined in the Circular sent to Shareholders and available to view on the Company's website, as published by the Company on 2 December 2021.

Enquiries:

 
 Abingdon Health plc                                   www.abingdonhealth.com/investors/ 
 Chris Yates, Chief Executive Officer                                    Via Walbrook PR 
 Melanie Ross , Chief Financial Officer 
 Christopher Hand, Non-Executive Chairman 
 
 Singer Capital Markets (Sole Broker and                        Tel: +44 (0)20 7496 3000 
  Nominated Adviser) 
 Shaun Dobson, Peter Steel, Alex Bond (Corporate 
  Finance) 
 Tom Salvesen (Corporate Broking) 
 
 Walbrook PR Limited                 Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com 
 Paul McManus / Phillip                          Mob: +44 (0)7980 541 893 / +44 (0)77867 
  Marriage                                                                       984 082 
 Alice Woodings                                                 Mob: +44 (0)7407 804 654 
 
 

About Abingdon Health

Abingdon Health is a world leading developer and manufacturer of high-quality rapid tests across all industry sectors, including healthcare and COVID-19. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and has also developed and marketed its own labelled tests.

The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx(R) , a customisable image capturing technology that transforms a smartphone into a self-sufficient, standalone lateral-flow reader.

Founded in 2008, Abingdon Health is headquartered in York, England.

For more information visit: www.abingdonhealth.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                          Chris Yates 
      --------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
      ----------------------------------------------------------------------------------------------------- 
 a)    Position/status                               Chief Executive Officer 
      --------------------------------------------  ------------------------------------------------------- 
 b)    Initial notification                          Initial Notification 
        /Amendment 
      --------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ----------------------------------------------------------------------------------------------------- 
 a)    Name                                          Abingdon Health plc 
      --------------------------------------------  ------------------------------------------------------- 
 b)    LEI                                           213800XFI4WV3FBILO20 
      --------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ----------------------------------------------------------------------------------------------------- 
 a)    Description of the                            Ordinary Shares of 0.025 pence each 
        financial instrument, 
        type of instrument 
 
       Identification code                           GB00BLF79J41 
 
 b)    Nature of the transaction                                Purchase of Ordinary Shares 
      --------------------------------------------  ------------------------------------------------------- 
 c)    Price(s) and volume(s) 
                                                     ----------------------------------------  ---------- 
                                                      Price(s)                                  Volume(s) 
                                                     ----------------------------------------  ---------- 
    25.00 pence                                                                                 1,000,000 
   ------------------------------------------------------------------------------------------  ---------- 
 
 d)    Aggregated information                          N/A - Single transaction 
 
 e)    Date of the transaction                       21 December 2021 
      --------------------------------------------  ------------------------------------------------------- 
 f)    Place of the transaction                                 Outside a trading venue 
      --------------------------------------------  ------------------------------------------------------- 
 
 
 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                          Dr Christopher Hand 
      --------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
      ----------------------------------------------------------------------------------------------------- 
 a)    Position/status                               Chairman 
      --------------------------------------------  ------------------------------------------------------- 
 b)    Initial notification                          Initial Notification 
        /Amendment 
      --------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ----------------------------------------------------------------------------------------------------- 
 a)    Name                                          Abingdon Health plc 
      --------------------------------------------  ------------------------------------------------------- 
 b)    LEI                                           213800XFI4WV3FBILO20 
      --------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ----------------------------------------------------------------------------------------------------- 
 a)    Description of the                            Ordinary Shares of 0.025 pence each 
        financial instrument, 
        type of instrument 
 
       Identification code                           GB00BLF79J41 
 
 b)    Nature of the transaction                                Purchase of Ordinary Shares 
      --------------------------------------------  ------------------------------------------------------- 
 c)    Price(s) and volume(s) 
                                                     ----------------------------------------  ---------- 
                                                      Price(s)                                  Volume(s) 
                                                     ----------------------------------------  ---------- 
    25.00 pence                                                                                 999,599 
   ------------------------------------------------------------------------------------------  ---------- 
 
 d)    Aggregated information                          N/A - Single transaction 
 
 e)    Date of the transaction                       21 December 2021 
      --------------------------------------------  ------------------------------------------------------- 
 f)    Place of the transaction                                 Outside a trading venue 
      --------------------------------------------  ------------------------------------------------------- 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHVFLBLFLLXFBV

(END) Dow Jones Newswires

December 21, 2021 03:40 ET (08:40 GMT)

Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Abingdon Health Charts.
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Abingdon Health Charts.